Johannes Gutenberg-Universität Mainz
- 6131/39-0
Hoffmann, Isabell; Diefenbach, Christiane; Gräf, Christine et al.
Chronic health conditions and school performance in first graders : a prospective cohort studyPLOS ONE. Bd. 13. H. 3. San Francisco, California, US: PLOS 2018 e0194846
Hoffmann, Isabel; Diefenbach, Christiane; Graef, Christine et al.
Chronic health conditions and school performance in first graders: A prospective cohort studyPLOS ONE. Bd. 13. H. 3. 2018
Ruder, Barbara; Murtadak, Vinay; Stuerzl, Michael et al.
Chronic intestinal inflammation in mice expressing viral Flip in epithelial cellsMUCOSAL IMMUNOLOGY. Bd. 11. H. 6. 2018 S. 1621-1629
van der Kooij, Michael A.; Jene, Tanja; Treccani, Giulia et al.
Chronic social stress-induced hyperglycemia in mice couples individual stress susceptibility to impaired spatial memoryProceedings of the National Academy of Sciences of the United States of America. Bd. 115. H. 43. Washington, DC: National Acad. of Sciences 2018 S. E10187 - E10196
Rutz, Jochen; Juengel, Eva; Euler, Stephanie et al.
Chronic Sulforaphane Application Does Not Induce Resistance in Renal Cell Carcinoma CellsANTICANCER RESEARCH. Bd. 38. H. 11. 2018 S. 6201-6207
Wilkens, Heinrike; Konstantinides, Stavros; Lang, Irene M. et al.
Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018INTERNATIONAL JOURNAL OF CARDIOLOGY. Bd. 272. 2018 S. 69-78
Escobar Pinzon, LC
Chronische Rückenschmerzen in der Pflege. Jede Zweite betroffen.2018
Jimenez-Alcazar, Miguel; Limacher, Andreas; Panda, Rachita et al.
Circulating extracellular DNA is an independent predictor of mortality in elderly patients with venous thromboembolismPLOS ONE. Bd. 13. H. 2. 2018
Haller, Nils; Helmig, Susanne; Taenny, Pascal et al.
Circulating, cell-free DNA as a marker for exercise load in intermittent sportsPLOS ONE. Bd. 13. H. 1. San Francisco, California, US: PLOS 2018 e0191915
Moehler, M.; Maderer, A.; Thuss-Patience, P. et al.
Cisplatin/5-fluorouracil plus /- panitumumab for patients with non-resectable, advanced or metastatic esophageal squamous cell cancer: A randomized phase III AIO/EORTC trial with an extensive biomarker programANNALS OF ONCOLOGY. Bd. 29. 2018